The DDI Study Had Been Designed to Investigate the Effect of SHR3680 on the Pharmacokinetics of Midazolam, S-Warfarin and Omeprazole

NCT04676035 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer Patients

Interventions

DRUG: Midazolam, Warfarin, Omeprazole, VitaminK1 and SHR3680

Sponsor

Jiangsu HengRui Medicine Co., Ltd.